Generic Wegovy, Ozempic compounds may become harder to get as FDA removes drug from shortage list
Compounding pharmacies producing cheaper semaglutide products have been given notice they will soon have to stop, as the drug ...
FDA says Ozempic shortage is over, chilling boom in off-brand versions
The FDA has now resolved the shortages of Novo Nordisk and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...
Novo's Wegovy and Ozempic removed from US FDA shortage list, compounders on notice
The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk's popular weight-loss and ...
UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT MARCH HEALTHCARE CONFERENCES
Universal Health Services, Inc. (NYSE: UHS) announced today that Steve Filton, Executive Vice President, and Chief Financial Officer will present at the following conferences: ...
UnitedHealth shares dive after report of US investigation into Medicare billing
UnitedHealth Group shares tumbled Friday on a report that the U.S. Department of Justice has started an investigation into ...
Behind the Scenes of CVS Health's Latest Options Trends
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...
FiercePharma6h
Novo Nordisk's semaglutide shortage officially concludes in the US, spelling major threat for weight loss drug compounders
Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...
Truist Financial Corp Decreases Stake in Johnson & Johnson (NYSE:JNJ)
Truist Financial Corp reduced its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 11.0% during the fourth quarter, ...
19,366 Shares in Envista Holdings Co. (NYSE:NVST) Bought by Empowered Funds LLC
Empowered Funds LLC acquired a new stake in shares of Envista Holdings Co. (NYSE:NVST – Free Report) in the 4th quarter, ...
Novo’s Ozempic Shortage Is Declared Over, Hitting Copycats
Novo Nordisk A/S’s weight-loss and diabetes drugs are no longer in short supply, US regulators said, a decision that’s ...